A Study on the Effect of Canagliflozin in Japanese Patients With Type 2 Diabetes and Microalbuminuria: Rationale, Design, and Baseline Characteristics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study
Diabetes Obes Metab 2022 Aug 01;24(8)1429-1438, S Miyamoto, HJL Heerspink, D de Zeeuw, M Toyoda, D Suzuki, T Hatanaka, T Nakamura, S Kamei, S Murao, K Hida, S Ando, H Akai, Y Takahashi, D Koya, M Kitada, H Sugano, T Nunoue, A Nakamura, M Sasaki, T Nakatou, K Fujimoto, D Kawanami, T Wada, N Miyatake, M Yoshida, K ShikataFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.